Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 32 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

19%

6 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

Phase 2
7(36.8%)
N/A
5(26.3%)
Phase 3
4(21.1%)
Phase 4
2(10.5%)
Phase 1
1(5.3%)
19Total
Phase 2(7)
N/A(5)
Phase 3(4)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials
NCT06417476Phase 2Active Not Recruiting

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Role: collaborator

NCT07353749Phase 4Not Yet Recruiting

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

Role: collaborator

NCT05728268Phase 2Recruiting

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Role: lead

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT06447701Phase 3Not Yet Recruiting

Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Role: collaborator

NCT06869200Not ApplicableEnrolling By Invitation

Study on the Use of a Concentrated Growth Factor Preparation Kit for the Treatment of Knee Osteoarthritis

Role: collaborator

NCT06241651Not ApplicableRecruiting

CSP Versus BiVP for Heart Failure Patients with RVP Upgraded to Cardiac Resynchronization Therapy

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT06458673Not Yet Recruiting

A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules

Role: collaborator

NCT06102824Phase 2Recruiting

Organoid-based Functional Precision Therapy for Advanced Breast Cancer

Role: collaborator

NCT06446778Recruiting

Pipeline Embolization for Intracranial Aneurysms

Role: collaborator

NCT04212494Not ApplicableRecruiting

Thrombus Aspiration in STEMI Patients With High Thrombus Burden

Role: collaborator

NCT03133598Completed

Treatment of Unruptured Intracranial Aneurysms in China

Role: collaborator

NCT04909554Completed

MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer

Role: collaborator

NCT06495034Not ApplicableRecruiting

Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema

Role: lead

NCT06162780Recruiting

TEER for Severe DMR of Low to Intermediate Surgery Risk

Role: collaborator

NCT05253768Phase 2Recruiting

Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus

Role: collaborator

NCT06220630Unknown

The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

Role: collaborator

NCT06001528Recruiting

Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer

Role: lead

NCT06032819Unknown

Differentiating Between Brain Hemorrhage and Contrast

Role: collaborator